Tomoi M - Search Results

1

Adenosine A1 receptor blockade reverses experimental postoperative ileus in rat colon.

Kadowaki M, Nagakura Y, Tokita K, Hanaoka K, Tomoi M. Kadowaki M, et al. Among authors: tomoi m. Eur J Pharmacol. 2003 Jan 1;458(1-2):197-200. doi: 10.1016/s0014-2999(02)02766-8. Eur J Pharmacol. 2003. PMID: 12498926

2

Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo.

Kadowaki M, Nagakura Y, Tomoi M, Mori J, Kohsaka M. Kadowaki M, et al. Among authors: tomoi m. J Pharmacol Exp Ther. 1993 Jul;266(1):74-80. J Pharmacol Exp Ther. 1993. PMID: 8331576

3

Combined blockade of 5-HT3- and 5-HT4-serotonin receptors inhibits colonic functions in conscious rats and mice.

Nagakura Y, Kontoh A, Tokita K, Tomoi M, Shimomura K, Kadowaki M. Nagakura Y, et al. Among authors: tomoi m. J Pharmacol Exp Ther. 1997 Apr;281(1):284-90. J Pharmacol Exp Ther. 1997. PMID: 9103508

4

Molecular identification and pharmacological characterization of adenosine receptors in the guinea-pig colon.

Kadowaki M, Takeda M, Tokita K, Hanaoka K, Tomoi M. Kadowaki M, et al. Among authors: tomoi m. Br J Pharmacol. 2000 Mar;129(5):871-6. doi: 10.1038/sj.bjp.0703123. Br J Pharmacol. 2000. PMID: 10696084 Free PMC article.

5

Adenosine A1 receptor blockade reverses dysmotility induced by ischemia-reperfusion in rat colon.

Kadowaki M, Tokita K, Nagakura Y, Takeda M, Hanaoka K, Tomoi M. Kadowaki M, et al. Among authors: tomoi m. Eur J Pharmacol. 2000 Dec 15;409(3):319-23. doi: 10.1016/s0014-2999(00)00867-0. Eur J Pharmacol. 2000. PMID: 11108827 Free article.

6

Pharmacological characterization of FK1052, a dihydropyridoindole derivative, as a new serotonin 3 and 4 dual receptor antagonist.

Nagakura Y, Kadowaki M, Tokoro K, Tomoi M, Mori J, Kohsaka M. Nagakura Y, et al. Among authors: tomoi m. J Pharmacol Exp Ther. 1993 May;265(2):752-8. J Pharmacol Exp Ther. 1993. PMID: 8496821

7

Pharmacological profile of FK480, a novel cholecystokinin type-A receptor antagonist: comparison to loxiglumide.

Ito H, Sogabe H, Nakarai T, Sato Y, Tomoi M, Kadowaki M, Matsuo M, Tokoro K, Yoshida K. Ito H, et al. Among authors: tomoi m. J Pharmacol Exp Ther. 1994 Feb;268(2):571-5. J Pharmacol Exp Ther. 1994. PMID: 7509389

8

FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.

Ishikawa H, Ito H, Higaki M, Higaki M, Matsumoto Y, Kamimura T, Katsura Y, Tomishi T, Inoue Y, Takasugi H, Tomoi M, Krakowka S, Yoshida K. Ishikawa H, et al. Among authors: tomoi m. Eur J Pharmacol. 1999 Aug 13;378(3):299-310. doi: 10.1016/s0014-2999(99)00466-5. Eur J Pharmacol. 1999. PMID: 10493106

9

Multiple mediators and mechanisms are involved in the adaptive cytoprotection provided by certain mild irritants.

Hatakeyama Y, Matsuo M, Tomoi M, Mori J, Kohsaka M. Hatakeyama Y, et al. Among authors: tomoi m. Jpn J Pharmacol. 1993 Oct;63(2):251-6. doi: 10.1254/jjp.63.251. Jpn J Pharmacol. 1993. PMID: 8283836 Free article.

10

FR149175, a beta 3-adrenoceptor-selective agonist, is a possible therapeutic agent for non-insulin-dependent diabetes mellitus.

Yamamoto H, Takakura S, Yamamoto T, Satoh H, Higaki M, Tomoi M, Shimomura K. Yamamoto H, et al. Among authors: tomoi m. Jpn J Pharmacol. 1997 May;74(1):109-12. doi: 10.1254/jjp.74.109. Jpn J Pharmacol. 1997. PMID: 9195306 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters